Daclahep 60mg Tablet (Daclatasvir)
Medicine OverView
Daclahep 60mg Tablet contains Daclatasvir, a prescription antiviral medicine used in the treatment of chronic hepatitis C virus (HCV) infection. It belongs to the class of medicines called direct-acting antivirals.
Daclatasvir works by stopping the hepatitis C virus from multiplying in the body. It is not used alone and must be taken together with other antiviral medicines as part of a complete hepatitis C treatment plan.
Daclahep 60mg Tablet is an oral antiviral medicine containing Daclatasvir 60 mg. It is used to treat chronic hepatitis C infection in adults as part of combination antiviral therapy.
Daclatasvir is commonly used with sofosbuvir, with or without ribavirin depending on the genotype, cirrhosis status, and previous treatment history. The exact combination and duration are decided by the treating doctor.
The exact use depends on the hepatitis C genotype, liver condition, previous treatment history, and the doctor’s recommendation.
Daclatasvir blocks the NS5A protein of the hepatitis C virus. This protein is essential for viral replication and assembly. By blocking NS5A, Daclahep 60mg Tablet helps stop the virus from multiplying and spreading in the body.
Its benefit depends on the complete combination regimen, patient adherence, viral genotype, and liver disease status.
The usual recommended dose of Daclatasvir is 60 mg once daily, taken with or without food, or exactly as prescribed by your doctor. The dose may need adjustment when used with certain medicines that affect liver enzymes.
The treatment duration and companion medicines vary based on the hepatitis C treatment plan.
Tell your doctor immediately if you develop extreme tiredness, yellowing of the eyes or skin, fainting, chest discomfort, or symptoms of a slow heartbeat.
Daclatasvir has important interactions with medicines that strongly affect CYP3A and P-gp pathways.
Always provide your doctor with a complete list of all medicines and supplements before starting Daclahep 60mg Tablet.
We focus on dependable service, privacy, and smooth access to prescription antiviral treatment support.
Daclahep 60mg Tablet is used in combination with other antiviral medicines to treat chronic hepatitis C infection.
Daclahep 60mg Tablet contains Daclatasvir 60 mg.
It is usually taken as one 60 mg tablet once daily, with or without food, exactly as prescribed by your doctor.
No. Daclatasvir should not be used alone for hepatitis C treatment and must be combined with other anti-HCV medicines.
Yes. Patients should be evaluated for current or prior hepatitis B because direct-acting antiviral therapy can reactivate HBV in some patients.
Yes. Rifampin is a major interaction and should generally be avoided because it can greatly reduce daclatasvir levels.
Common side effects include headache, tiredness, nausea, and weakness.
Yes. Daclahep 60mg Tablet is a prescription medicine and should only be used under medical supervision.
What do you think about this product?